These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26901563)

  • 1. Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe, Malawi.
    Kim MH; Zhou A; Mazenga A; Ahmed S; Markham C; Zomba G; Simon K; Kazembe PN; Abrams EJ
    PLoS One; 2016; 11(2):e0149527. PubMed ID: 26901563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of male partner involvement in ART retention and adherence in Malawi's Option B+ program.
    Wesevich A; Mtande T; Saidi F; Cromwell E; Tweya H; Hosseinipour MC; Hoffman I; Miller WC; Rosenberg NE
    AIDS Care; 2017 Nov; 29(11):1417-1425. PubMed ID: 28355926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
    Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
    BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of inter-partner HIV disclosure patterns in Malawi's PMTCT program: A mixed-method study.
    van Lettow M; Cataldo F; Landes M; Kasende F; Nkhoma P; van Oosterhout JJ; Kim E; Schouten E; Nkhoma E; Nyirenda R; Tippett Barr BA
    PLoS One; 2019; 14(7):e0219967. PubMed ID: 31348782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring factors associated with ART adherence and retention in care under Option B+ strategy in Malawi: A qualitative study.
    Gugsa S; Potter K; Tweya H; Phiri S; Sande O; Sikwese P; Chikonda J; O'Malley G
    PLoS One; 2017; 12(6):e0179838. PubMed ID: 28636669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.
    Tabatabai J; Namakhoma I; Tweya H; Phiri S; Schnitzler P; Neuhann F
    Glob Health Action; 2014; 7():24795. PubMed ID: 25280736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing postnatal Option B+ participation and breastfeeding duration among HIV-positive women in Lilongwe District, Malawi: A qualitative study.
    Flax VL; Hamela G; Mofolo I; Hosseinipour MC; Hoffman IF; Maman S
    PLoS One; 2017; 12(4):e0175590. PubMed ID: 28410374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
    Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
    J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
    Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
    PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
    Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
    Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female adherence self-efficacy before and after couple HIV testing and counseling within Malawi's Option B+ program.
    Wesevich A; Hosseinipour MC; Golin CE; McGrath N; Tsidya M; Chimndozi L; Bhushan N; Hoffman I; Miller WC; Rosenberg NE
    AIDS Care; 2020 Feb; 32(2):170-174. PubMed ID: 31238717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
    Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
    BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.
    Haas AD; Msukwa MT; Egger M; Tenthani L; Tweya H; Jahn A; Gadabu OJ; Tal K; Salazar-Vizcaya L; Estill J; Spoerri A; Phiri N; Chimbwandira F; van Oosterhout JJ; Keiser O
    Clin Infect Dis; 2016 Nov; 63(9):1227-1235. PubMed ID: 27461920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+).
    van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ
    J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'I wanted to safeguard the baby': a qualitative study to understand the experiences of Option B+ for pregnant women and the potential implications for 'test-and-treat' in four sub-Saharan African settings.
    McLean E; Renju J; Wamoyi J; Bukenya D; Ddaaki W; Church K; Zaba B; Wringe A
    Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative analysis of the barriers and facilitators to receiving care in a prevention of mother-to-child program in Nkhoma, Malawi.
    Iroezi ND; Mindry D; Kawale P; Chikowi G; Jansen PA; Hoffman RM
    Afr J Reprod Health; 2013 Dec; 17(4 Spec No):118-29. PubMed ID: 24689323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
    Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
    PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi.
    Kim MH; Tembo TA; Mazenga A; Yu X; Myer L; Sabelli R; Flick R; Hartig M; Wetzel E; Simon K; Ahmed S; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Markham C; Ciaranello A; Abrams EJ
    Trials; 2020 Feb; 21(1):207. PubMed ID: 32075677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.